SENSITIVITY OF MULTIDRUG-RESISTANT TUMOR-CELL LINES TO IMMUNOLOGICAL EFFECTOR-CELLS

被引：0
|
作者：
SCHMIDTWOLF, IGH
LEFTEROVA, P
JOHNSTON, V
SCHEFFOLD, C
CSIPAI, M
MEHTA, BA
TSURUO, T
HUHN, D
NEGRIN, RS
机构：
[1] FREE UNIV BERLIN,INNERE MED ABT,W-1000 BERLIN 33,GERMANY
[2] STANFORD UNIV,MED CTR,BONE MARROW TRANSPLANT PROGRAM,STANFORD,CA 94305
[3] CANC CHEMOTHERAPY CTR,DIV EXP CHEMOTHERAPY,TOSHIMA KU,TOKYO,JAPAN
来源：
BLOOD | 1994年 / 84卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A500 / A500
页数：1
相关论文
共 50 条
  • [1] Sensitivity of multidrug-resistant tumor cell lines to immunologic effector cells
    SchmidtWolf, IGH
    LEfterova, P
    Johnston, V
    Scheffold, C
    Csipai, M
    Mehta, BA
    Tsuruo, T
    Huhn, D
    Negrin, RS
    [J]. CELLULAR IMMUNOLOGY, 1996, 169 (01) : 85 - 90
  • [2] EFFECTS OF 8-CHLORO-CYCLIC ADENOSINE-MONOPHOSPHATE ON THE GROWTH AND SENSITIVITY TO DOXORUBICIN OF MULTIDRUG-RESISTANT TUMOR-CELL LINES
    BORSELLINO, N
    CRESCIMANNO, M
    LEONARDI, V
    DALESSANDRO, N
    [J]. PHARMACOLOGICAL RESEARCH, 1994, 30 (01) : 81 - 90
  • [3] BIOLOGY, CYTOGENETICS, AND SENSITIVITY TO IMMUNOLOGICAL EFFECTOR-CELLS OF NEW HEAD AND NECK SQUAMOUS-CELL CARCINOMA LINES
    HEO, DS
    SNYDERMAN, C
    GOLLIN, SM
    PAN, S
    WALKER, E
    DEKA, R
    BARNES, EL
    JOHNSON, JT
    HERBERMAN, RB
    WHITESIDE, TL
    [J]. CANCER RESEARCH, 1989, 49 (18) : 5167 - 5175
  • [4] STUDY OF THE RESISTANCE OF TUMOR-CELL SPHEROIDS TO PENETRATION AND LYSIS BY ACTIVATED EFFECTOR-CELLS
    OCHALEK, T
    VONKLEIST, S
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1994, 57 (03) : 399 - 405
  • [5] Increased sensitivity of multidrug-resistant myeloid leukemia cell lines to lovastatin
    L Maksumova
    K Ohnishi
    F Muratkhodjaev
    W Zhang
    L Pan
    A Takeshita
    R Ohno
    [J]. Leukemia, 2000, 14 : 1444 - 1450
  • [6] REVERSAL OF ETOPOSIDE RESISTANCE IN NON-P-GLYCOPROTEIN EXPRESSING MULTIDRUG-RESISTANT TUMOR-CELL LINES BY NOVOBIOCIN
    RAPPA, G
    LORICO, A
    SARTORELLI, AC
    [J]. CANCER RESEARCH, 1993, 53 (22) : 5487 - 5493
  • [7] Increased sensitivity of multidrug-resistant myeloid leukemia cell lines to lovastatin
    Maksumova, L
    Ohnishi, K
    Muratkhodjaev, F
    Zhang, W
    Pan, L
    Takeshita, A
    Ohno, R
    [J]. LEUKEMIA, 2000, 14 (08) : 1444 - 1450
  • [8] COMBINATIVE GROWTH-INHIBITORY EFFECTS OF INTERFERON-ALPHA AND DOXORUBICIN ON MULTIDRUG-RESISTANT TUMOR-CELL LINES
    LEONARDI, V
    BORSELLINO, N
    CRESCIMANNO, M
    FLANDINA, C
    FLUGY, A
    DALESSANDRO, N
    [J]. ONCOLOGY REPORTS, 1994, 1 (01) : 161 - 164
  • [9] TUMOR-CELL SUSCEPTIBILITY TO CYTO-TOXIC OR CYTOSTATIC EFFECTOR-CELLS INVITRO AND THE REGULATION OF TUMOR-CELL GROWTH-INVIVO
    GORCZYNSKI, RM
    MACRAE, S
    [J]. BRITISH JOURNAL OF CANCER, 1981, 43 (01) : 32 - 43
  • [10] Antimitotic agents with activity in multidrug-resistant tumor cell lines.
    Szczepankiewicz, BG
    Liu, G
    Tasker, AS
    Sorensen, BK
    von Geldern, TW
    Jae, HS
    Winn, M
    Gwaltney, SL
    Kester, JA
    Pei, ZH
    Wu-Wong, JR
    Gehrke, L
    Chiou, WJ
    Credo, RB
    Lee, JY
    Warner, RB
    Alder, JD
    Nukkala, MA
    Zielinski, NA
    Marsh, KC
    Rosenberg, SH
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U25 - U25
12345